W. van den Berg

4.4k total citations
85 papers, 3.3k citations indexed

About

W. van den Berg is a scholar working on Plant Science, Molecular Biology and Immunology. According to data from OpenAlex, W. van den Berg has authored 85 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Plant Science, 22 papers in Molecular Biology and 18 papers in Immunology. Recurrent topics in W. van den Berg's work include Nematode management and characterization studies (11 papers), Osteoarthritis Treatment and Mechanisms (10 papers) and Cytokine Signaling Pathways and Interactions (8 papers). W. van den Berg is often cited by papers focused on Nematode management and characterization studies (11 papers), Osteoarthritis Treatment and Mechanisms (10 papers) and Cytokine Signaling Pathways and Interactions (8 papers). W. van den Berg collaborates with scholars based in Netherlands, Germany and United States. W. van den Berg's co-authors include Pierre Miossec, Arjen B. Blom, Leo A. B. Joosten, Erik Lubberts, Martine Chabaud, Georg Schett, Marije I. Koenders, Jochen Zwerina, P.M. van der Kraan and Christian Jørgensen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

W. van den Berg

80 papers receiving 3.2k citations

Peers

W. van den Berg
Myles Lewis United Kingdom
Koji Ito Japan
Sanjay Gupta United States
Marion K. Gordon United States
S. P. Raychaudhuri United States
Xia Li China
Jeffrey C. Edberg United States
W. van den Berg
Citations per year, relative to W. van den Berg W. van den Berg (= 1×) peers Wanling Yang

Countries citing papers authored by W. van den Berg

Since Specialization
Citations

This map shows the geographic impact of W. van den Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. van den Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. van den Berg more than expected).

Fields of papers citing papers by W. van den Berg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. van den Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. van den Berg. The network helps show where W. van den Berg may publish in the future.

Co-authorship network of co-authors of W. van den Berg

This figure shows the co-authorship network connecting the top 25 collaborators of W. van den Berg. A scholar is included among the top collaborators of W. van den Berg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. van den Berg. W. van den Berg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stock, Michael, Alfiya Distler, Ursula Schlötzer‐Schrehardt, et al.. (2017). A Dual Role of Upper Zone of Growth Plate and Cartilage Matrix–Associated Protein in Human and Mouse Osteoarthritic Cartilage: Inhibition of Aggrecanases and Promotion of Bone Turnover. Arthritis & Rheumatology. 69(6). 1233–1245. 24 indexed citations
2.
Joosten, Leo A. B., et al.. (2016). Interleukin-1 does not aggravate joint inflammation and cartilage destruction in experimental osteoarthritis. Osteoarthritis and Cartilage. 24. S326–S326. 2 indexed citations
3.
Berg, W. van den, et al.. (2016). Secukinumab for rheumatology: development and its potential place in therapy. Drug Design Development and Therapy. Volume 10. 2069–2080. 31 indexed citations
4.
Bon, Lenny van, Marta Cossu, Alwin Scharstuhl, et al.. (2016). Low heme oxygenase-1 levels in patients with systemic sclerosis are associated with an altered Toll-like receptor response: another role for CXCL4?. Lara D. Veeken. 55(11). 2066–2073. 16 indexed citations
5.
Brkić, Zana, Lenny van Bon, Marta Cossu, et al.. (2015). The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis. Annals of the Rheumatic Diseases. 75(8). 1567–1573. 131 indexed citations
6.
Köffel, René, Anastasia Meshcheryakova, Joanna Warszawska, et al.. (2014). Monocytic cell differentiation from band-stage neutrophils under inflammatory conditions via MKK6 activation. Blood. 124(17). 2713–2724. 31 indexed citations
7.
Cossu, Marta, Arnoud Loof, Faekah Gohar, et al.. (2014). Proteomic analysis of plasma identifies the Toll-like receptor agonists S100A8/A9 as a novel possible marker for systemic sclerosis phenotype. Annals of the Rheumatic Diseases. 73(8). 1585–1589. 66 indexed citations
8.
Koenders, Marije I., Axel J. Hueber, Renoud J. Marijnissen, et al.. (2011). Anti IL‐17A therapy inhibits bone loss in TNF‐α‐mediated murine arthritis by modulation of the T‐cell balance. European Journal of Immunology. 42(2). 413–423. 46 indexed citations
9.
Krönke, Gerhard, Julia Katzenbeisser, Stefan Uderhardt, et al.. (2009). 12/15-Lipoxygenase Counteracts Inflammation and Tissue Damage in Arthritis. The Journal of Immunology. 183(5). 3383–3389. 137 indexed citations
10.
Polzer, K, Leo A. B. Joosten, Jürg A. Gasser, et al.. (2009). Interleukin-1 is essential for systemic inflammatory bone loss. Annals of the Rheumatic Diseases. 69(1). 284–290. 108 indexed citations
11.
Dahlén, Eva, Karin Barchan, Marie Karlsson, et al.. (2008). Development of Interleukin-1 Receptor Antagonist Mutants with Enhanced Antagonistic ActivityIn Vitroand Improved Therapeutic Efficacy in Collagen-Induced Arthritis. Journal of Immunotoxicology. 5(2). 189–199. 5 indexed citations
12.
Zwerina, Jochen, Kurt Redlich, Karin Polzer, et al.. (2007). TNF-induced structural joint damage is mediated by IL-1. Proceedings of the National Academy of Sciences. 104(28). 11742–11747. 225 indexed citations
13.
Blom, Arjen B., P.M. van der Kraan, & W. van den Berg. (2007). Cytokine Targeting in Osteoarthritis. Current Drug Targets. 8(2). 283–292. 94 indexed citations
14.
Netea, Mihai G., Leo A. B. Joosten, Eli C. Lewis, et al.. (2006). Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nature Medicine. 12(6). 650–656. 350 indexed citations
16.
Chabaud, Martine, et al.. (2001). IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Research & Therapy. 3(3). 168–77. 267 indexed citations
17.
Meurs, Joyce B. J. van, Peter van Lent, A. E. M. Holthuysen, et al.. (1999). Active Matrix Metalloproteinases Are Present in Cartilage During Immune Complex-Mediated Arthritis: A Pivotal Role for Stromelysin-1 in Cartilage Destruction. The Journal of Immunology. 163(10). 5633–5639. 62 indexed citations
18.
Berg, W. van den, et al.. (1998). Residentiële segregatie in Hollandse steden. Theorie, methodologie en empirische bevindingen voor Alkmaar en Amsterdam, 16e-19e eeuw. UvA-DARE (University of Amsterdam). 24(4). 2 indexed citations
19.
Werf, Hayo van Der & W. van den Berg. (1995). Nitrogen fertilization and sex expression affect size variability of fibre hemp (Cannabis sativa L.). Oecologia. 103(4). 462–470. 22 indexed citations
20.
Berg, W. van den, C. Breederveld, J W ten Cate, Marjolein Peters, & J.J.J. Borm. (1989). Low antithrombin III: accurate predictor of idiopathic respiratory distress syndrome in premature neonates. European Journal of Pediatrics. 148(5). 455–458. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026